Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
514212, 514318, 514319, 514320, 514408, 540484, 546192, 546195, 546205, 546213, 548400, 548579, A61K 31445, C07D21114
New 2-(arylalkenyl)azacycloalkane derivatives which are ligands for sigma receptors, of the formula (I) ##STR1## in which: Ar is aryl or heteroaryl, optionally mono- to trisubstituted,
patent: 5034419 (1991-07-01), Aubard et al.
patent: 5089639 (1992-02-01), Aubard et al.
Goldner, F. H., and Kraft, S. C., "Idopathic Inflammatory Bowel Disease," Internal Medicine, 4.sup.th ed., J. H. Stein, editor, (St. Louis: Mosby, 1994), pp. 458-470.
Stein, J. H., et al., Internal Medicine, 4.sup.th ed., J. H. Stein, (St. Louis, Mosby, 1994), pp. 443-445.
PCT International Search Report, mailing date Dec. 9, 1994.
Calvet Alain Pierre
Ashbrook Charles W.
Raymond Richard L.
Warner-Lambert & Company
2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with 2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1462587